 |
BAROnova®, Inc., founded in 2006 and based in Goleta, CA, is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.
BAROnova closed its Series B financing of $7.5 million to continue the clinical development of their TransPyloric Shuttle® weight-loss system*. This technology focuses on potentially slowing a person's gastric emptying, which is a known mechanism of action for weight loss. To date, the TransPyloric Shuttle has been studied in both animals and humans with favorable results.
*The BAROnova TransPyloric Shuttle is not available for sale within the United States or internationally.
|
|
